MacroGenics Inc (MGNX)
Healthcare
Biotechnology
3.80 $
+3.5%
vs. previous close
Closing price · As of: 3. Aug 2026
MacroGenics Inc (MGNX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -81 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -33 | -14 | -44 | 14 | -153 | -134 | -112 | -144 | -87 | -78 | -68 | -81 | |
| 1.8 | 2.9 | 7.6 | 7.2 | 8.3 | 11 | 12 | 11 | 12 | 9.6 | 7.5 | 5.5 | |
| 3.2 | 7.8 | 12 | 15 | 17 | 20 | 21 | 23 | 20 | 18 | 29 | 14 | |
| 3.2 | 7.8 | 12 | 15 | 17 | 18 | 21 | 25 | 23 | – | – | – | |
| 0.5 | -4.2 | -4.9 | 12 | -6.6 | -13 | -15 | 18 | -6.1 | 53 | 1.4 | -28 | |
| 3.6 | 9.2 | 11 | 29 | 25 | 4.3 | 5.9 | 6.2 | 3.6 | 1.8 | 3.7 | 1.9 | |
| -3.6 | -152 | -70 | 78 | 57 | -79 | -7.8 | -37 | 71 | -80 | 149 | -114 | |
| 0.0 | 0.0 | 0.0 | 0.0 | – | – | – | – | – | – | – | – | |
| 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | 0.0 | -2.0 | 118 | 1.1 | -0.3 | – | – | |
| 77 | 204 | 1.9 | 35 | 105 | 120 | 174 | 123 | 1.7 | 150 | 1.0 | 70 | |
| 41 | 39 | -112 | 128 | 8.4 | -94 | 55 | -58 | -15 | -7.9 | 82 | -126 | |
| -36 | -23 | -55 | -15 | -178 | -139 | -118 | -150 | -91 | -80 | -72 | -83 |
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.